ELV Elevance Health, Inc. Common Stock

NYSE · Health Care · View on SEC EDGAR ↗
$399.76
Price · Aug 21, 2026
Fundamentals as of Jul 15, 2026

About Elevance Health, Inc. Common Stock Company overview from Wikipedia

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

Read more

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing (BPO)/Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States.

History

Anthem

In 1946, Anthem began in Indianapolis, Indiana, as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. The companies grew significantly, controlling 80% of the medical insurance market in Indiana by the 1970s.

In 1972, the two firms, then known as Blue Cross of Indiana and Blue Shield of Indiana, entered into a joint operating agreement.

In 1985, the two companies merged into Associated Insurance Companies, Inc,, later called, The Associated Group, a holding company, but usage of the name "Anthem" persisted. In 1989, the company purchased American General Insurance Co. for $150 million and in 1991, it acquired The Shelby Insurance Co., based in Shelby, Ohio, for $125 million. In 1989, The Associated Group founded Acordia, a brokerage that sold and serviced insurance and employee benefit programs.

In 1993, Acordia acquired American Business Insurance for $130 million and the Federal Kemper Insurance Company for $100 million. The Associated Group merged with Southeastern Mutual Insurance Company, the operator of Blue Cross and Blue Shield of Kentucky. In 1994, it sold Raffensperger, Hughes & Co., Inc., Indiana's largest investment bank, to National City Corp.

In 1995, The Associated Group acquired Community Mutual Insurance, a provider of Blue Cross and Blue Shield insurance plans in Ohio with over 1.9 million policy holders), then set up Anthem Blue Cross and Blue Shield. In 1996, The Associated Group changed its name to Anthem Insurance Company. In August 1997, Anthem acquired Blue Cross and Blue Shield of Connecticut. It also sold Acordia to management.

In 1999, Anthem acquired Blue Cross and Blue Shield of New Hampshire and Blue Cross and Blue Shield of Colorado and Nevada, using debt financing. The acquisitions made since 1996 added 850,000 policy holders. Among its customer base were 2.4 million PPO and 964,000 HMO enrollees.

In 2000, Anthem acquired Blue Cross Blue Shield of Maine. The Gramm-Leach-Bliley Act of 1999 made it possible for Anthem to undergo demutualization and become a public company via an initial public offering, which made it the fourth largest public managed health care company in the United States.

In 2002, Anthem acquired Trigon Healthcare of Virginia, a Blue Cross and Blue Shield plan, the largest insurer in Virginia, for $4.04 billion. Anthem Insurance Company reached 11.9 million members.

Blue Cross of California

Blue Cross of California was the predecessor of WellPoint Health Network Inc.

In 1982, Blue Cross of California was founded with the consolidation of Blue Cross of Northern California (established in 1936) and Blue Cross of Southern California (established in 1937).

In 1992, WellPoint was formed to operate Blue Cross of California's managed care business. In January 1993, Blue Cross of California spun off its managed care business into a publicly traded entity, WellPoint Health Networks Inc. Blue Cross of California retained an 80% interest and voting control.

In 1996, Blue Cross of California restructured to a for-profit corporation, designating WellPoint Health Networks Inc. as the parent organization. In April 1996, WellPoint completed its acquisition of Massachusetts Mutual Life Insurance Company's group life and health insurance subsidiaries for approximately $380 million, making it the second largest publicly held managed health company in the U.S. with 4 million policyholders.

In March 1997, WellPoint acquired the group health and life businesses of John Hancock Financial for $86.7 million. With this acquisition, WellPoint expanded its presence into Michigan, Texas, and the mid-Atlantic, and gained a unit that concentrated on serving the needs of large employers.

In 2000, WellPoint acquired PrecisionRx, a mail service pharmacy fulfillment center in Texas. In March 2000, WellPoint acquired Rush Prudential Health Plans, a Chicago provider, for $204 million. In March 2001, WellPoint acquired Cerulean Companies, the parent company of Blue Cross Blue Shield of Georgia. In 2001, WellPoint offered to acquire CareFirst BlueCross BlueShield for $1.37 billion, including $119 million in bonuses to Carefirst executives. In 2003, the offer was rejected by the Maryland insurance commissioner.

In 2002, WellPoint acquired RightChoice Managed Care, a Missouri-based company that ran Blue Cross and Blue Shield for part of the state, for $1.5 billion. RightChoice also owned provider network company HealthLink. WellPoint also acquired MethodistCare of Houston, Texas and HealthLink. In 2003, WellPoint acquired Golden West Dental and Vision of Camarillo, California, and Cobalt, including Blue Cross and Blue Shield United of Wisconsin.

In November 2004, Wellpoint, Inc. was formed by the merger of Anthem Insurance Company and WellPoint Health Networks Inc. The merger was structured as Anthem acquiring WellPoint Health Networks and renaming itself WellPoint, Inc. WellPoint continued to use 'Anthem' as the brand name under which it operated. It sold its Blue Cross and Blue Shield products in 11 states.

In 2005, WellPoint acquired Alexandria, Virginia–based Lumenos, a provider of consumer-driven health care, for $185 million. Lumenos was the pioneer and market leader in consumer-driven health plans. In December, WellPoint acquired WellChoice, a New York City-based Blue Cross Blue Shield provider, for approximately $6.5 billion, making New York the 14th state in which WellPoint is a Blue Cross Blue Shield licensee.

In 2007, WellPoint acquired Chicago-based American Imaging Management, a radiology benefit management company that creates software to help physicians choose cost-effective locations for their patients to receive medical imaging tests. WellPoint also acquired Chicago-based American Imaging Management (AIM), the leading radiology benefit management company.

In January 2008, Leslie Margolin became the president of California operations. She resigned in July 2010. In 2008, WellPoint acquired Resolution Health, a firm that analyzes patient history for potential medical problems such as adverse drug interactions. In 2009, WellPoint acquired DeCare Dental, a dental insurance firm.

In 2011, WellPoint acquired CareMore, a Cerritos, California-based provider of insurance and care centers for elderly patients. In 2012, WellPoint acquired Amerigroup for $4.9 billion, anticipating significant growth due to Medicaid expansion under the Patient Protection and Affordable Care Act. In August 2012, CEO Angela Braly resigned due to pressure from investors.

On August 13, 2014, WellPoint announced it intended to change its name to Anthem, Inc., effective in December.

Anthem, Inc.

In February 2015, the company acquired Simply Healthcare Holdings, a Medicaid and Medicare managed care company based in Florida. In June 2015, Anthem made an offer to acquire Cigna for more than $54 billion in cash and stock. In February 2017, United States district court Judge Amy Berman Jackson blocked the Cigna merger on grounds of anti-competitive practices. On February 14, Cigna called off its merger agreement with Anthem.

In October 2017, Anthem announced that it would not renew its pharmacy benefit management (PBM) relationship with Express Scripts saying it had been overcharged $3 billion and that instead, Anthem would eventually handle the PBM process itself through its new IngenioRx unit. Anthem announced that it would enter a 5-year contract with CVS Health. Cigna then announced plans in March 2018 to acquire Express Scripts for $58 billion. On November 6, 2017, Gail Koziara Boudreaux was named CEO. In 2018, the company announced a $20 million expansion of its headquarters and the signing of a lease in Atlanta for its technology center. In March 2020, Anthem announced the acquisition of Beacon Health Options, and independently held behavioral health organization.

On February 2, 2021, Anthem announced the acquisition of InnovaCare Health's Puerto Rico subsidiaries including MMM Holdings, LLC ("MMM") and its Medicare Advantage (MA) plan MMM Healthcare, LLC as well as affiliated companies and Medicaid plan. In November 2021, Anthem announced the acquisition of Integra Managed Care in New York. The acquisition of the New York-based international health insurance company was completed on May 5, 2022.

On June 28, 2022, Anthem announced a change of its corporate name to Elevance Health, Inc. and also changed its stock ticker symbol from "ANTM" to "ELV".

Elevance Health

On January 23, 2023, Elevance announced that it entered a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana, increasing Elevance's footprint to 15 states and adding 1.9 million new members. In 2023, Elevance announced that it would rebrand its Amerigroup business as Wellpoint starting in 2024.

As of 2025, Elevance subsidiaries Carelon Behavioral Health and Anthem Blue Cross and Blue Shield are the subject of three lawsuits in New York and Connecticut alleging that they operate ghost networks.

Subsidiaries

Elevance Health includes the following subsidiaries:

Amerigroup

District of Columbia (Medicaid)

Georgia (Medicaid)

New Mexico (Medicare Advantage)

Anthem Blue Cross

California

Blue Cross of California Partnership Plan (Medicaid)

New York (upstate)

Anthem Blue Cross Blue Shield

Colorado

Connecticut

Georgia

Indiana (includes Medicaid)

Kentucky

Anthem Blue Cross and Blue Shield Medicaid

Maine

Missouri (excluding 30 counties in the Kansas City area)

Nevada

Anthem Blue Cross and Blue Shield Healthcare Solutions (Medicaid)

New Hampshire

New York (downstate)

HealthPlus (Medicaid)

Ohio

Virginia (excluding Alexandria City, Arlington County, Falls Church City, and parts of Fairfax County)

HealthKeepers (Medicaid)

Wisconsin

Carelon Behavioral Health

Carelon Behavioral Health of California

Carelon Behavioral Health of Kansas

Carelon Health of Pennsylvania

Carelon Global Solutions (Business Process Outsourcing/Shared Services)

Freedom Health

Florida

Golden West Dental & Vision

California

HealthSun

Florida

MMM

Puerto Rico

Optimum Healthcare

Florida

Simply Healthcare

Florida

UniCare

West Virginia

WellPoint

Arizona (Medicare Advantage)

Iowa (Medicaid and Medicare Advantage)

Maryland (Medicaid)

Massachusetts (government employees)

New Jersey (Medicaid and Medicare Advantage)

Tennessee (Medicaid and Medicare Advantage)

Texas (Medicaid and Medicare Advantage)

Washington (Medicaid and Medicare Advantage)

Joint ventures

Elevance Health operates joint ventures including:

Anthem | MaineHealth (with MaineHealth)

Maine

Blue Medicare Advantage (with Independence Blue Cross)

Pennsylvania

Colorado Community Health Alliance (with Centura Health, Physician Health Partners and Primary Physician Partners)

Colorado

Healthy Blue Kansas (with Blue Cross and Blue Shield of Kansas and Blue Cross and Blue Shield of Kansas City)

Kansas

Healthy Blue Louisiana (with Blue Cross Blue Shield of Louisiana)

Louisiana

Summit Community Care

Arkansas

Centers Plan for Healthy Living

New York, Florida

Quality of care

In 2011, in the category of "Meeting National Standards of Care," California's state patient advocacy office gave Anthem a rating of 2 out of 4 stars. In 2014, it received 3 out of 4 stars in the same category. In 2022, twenty-one of Elevance Health's affiliated Medicaid plans earned accreditation for health equity from the National Committee for Quality Assurance (NCQA).

Controversies

Charitable donations

In 2007, WellPoint pledged to spend $30 million over three years, through the company's charitable foundation, to help the uninsured. In March 2010, the Los Angeles Times reported that WellPoint's tax records and website showed that the company had given only $6.2 million by 2009. The company said that the foundation had indeed fulfilled its $30-million commitment by mid-2009, but refused to provide any financial details to support its claim.

2007 DMHC investigation

In 2007, the California Department of Managed Health Care (DMHC) investigated Anthem's policies for revoking (rescinding) health care insurance policies. The DMHC randomly selected 90 instances where Anthem canceled the insurance of policy holders who had been diagnosed with costly or life-threatening illnesses, to find how many of these cancellations were legal. The agency concluded that all these cancellations were illegal.

In July 2008, Anthem Blue Cross agreed to a settlement with the California Department of Managed Health Care; however in doing so, WellPoint did not officially admit liability. To resolve allegations of improper policy rescissions (cancellations), WellPoint paid $10 million and reinstated plans for 1,770 policy-holders who were affected by cancelled policies. The company also agreed to provide compensation for any medical debts incurred by these policy-holders.

2010 Reuters exposé

In April 2010, Reuters alleged that Wellpoint "using a computer algorithm, identified women recently diagnosed with breast cancer and then singled them out for cancellation of their policies." The software used immediately triggered fraud investigation for those recently diagnosed with the disease as the company searched for some pretext to drop their policies. Wellpoint argued that its algorithm was scanning for diagnostic codes for conditions that patients might have known about during the insurance application. The story not only caused considerable public outrage, but it also led Secretary of Health and Human Services, Kathleen Sebelius, and President Barack Obama, to call on WellPoint to end the practice.

In 2011, Anthem began cancelling policies of members who had been paying premiums with credit cards, sometimes without calling or emailing the member ahead of time.

Opposition to healthcare reform

In August 2009, Anthem, the largest for-profit insurer in California, contacted its employees and urged them to get involved to oppose healthcare reforms proposed during the Obama administration. Consumer Watchdog, a nonprofit watchdog organization in Santa Monica, asked California Attorney General Jerry Brown to investigate its claim that WellPoint had illegally pushed workers to write to their elected officials, attend town hall meetings and enlist family and friends to ensure an overhaul that would match the firm's interests. According to Consumer Watchdog, California's labor code directly prohibits coercive communications, including forbidding employers from controlling, coercing or influencing employees' political activities or affiliations. WellPoint had not been contacted by the California attorney general and had not seen any complaint.

Through 2010 and into 2011, WellPoint senior executives met monthly with executives of other major health insurers to blunt the effect of the Patient Protection and Affordable Care Act.

Premium increases in Maine

In 2009, Anthem Health Plans of Maine, a WellPoint subsidiary, sued the state of Maine for the right to increase premiums further. Since Maine licenses insurance companies through its Bureau of Insurance, Anthem needed the state's permission to raise rates. The Court disagreed with Anthem and found that, unlike with other forms of insurance, the Maine Insurance Code does not require the Superintendent to consider profits.

Rate increases in California

In February 2010, WellPoint announced that rates would increase on some Anthem Blue Cross individual policies in California by as high as 39%. The announcement resulted in an investigation by regulators from the Federal and California governments. Anthem Blue Cross gained worldwide media attention and became a poster child for the problem of rising cost of health care in the U.S. The rate increase came one year after Anthem had raised rates 68% on individual policy holders.

To explain the rate increases, some which were four times the rate of medical inflation, Anthem said the company had experienced a death spiral: the company claimed that with increased unemployment and declining wages, healthy customers dropped their insurance policies. Consequently, the remaining risk pool became sicker and thus more expensive to insure; and, in turn, prices were forced up and pushed more people out of the market.

In response to the outrage from politicians and consumers, Anthem postponed the rate increase until May 1, 2010.

Senator Dianne Feinstein of California proposed giving the Federal government of the United States authority to block insurance premium hikes that it considers to be "unjustified".

WellPoint cost reclassification

On March 17, 2010, WellPoint announced it was reclassifying some of its administrative costs as medical care costs in order to meet loss ratio requirements under the Patient Protection and Affordable Care Act, which requires insurers to spend at least 80% or 85% of customer premiums on health care services, depending on the type of plan.

2009–2010 data breach

In June 2010, Anthem sent letters to 230,000 customers in California warning them that their personal data might have been accessed online via a data breach. After a routine upgrade in October 2009, a third-party vendor stated that all security measures had been properly reinstated, when in fact they had not. As a result, personal information of thousands of coverage applicants who were under the age of 65 was exposed in the open. After a Los Angeles-area woman found that her application for coverage was publicly available, she filed a class action lawsuit against Anthem. While gathering evidence for the proceeding, the woman's lawyers downloaded some confidential customer information from Anthem's website and alerted Anthem about the breach. According to the lawyers, confidential information had remained exposed for five months. Greg Zoeller, Indiana's Attorney General, filed a lawsuit against the company seeking $300,000 in civil penalties for the company alleged failure to notify its consumers about the breach.

Denial of benefits for cancer treatment

In May 2014, Anthem Blue Cross refused to pay for the hospitalization of a Sonoma County, California man for stage four cancers, although he had paid Anthem over $100,000 in premiums. Anthem ended up paying for coverage following public outcry.

2015 data breach

On February 4, 2015, Anthem, Inc. disclosed that criminal hackers had broken into its servers and potentially stolen over 37.5 million records that contain personally identifiable information from its servers. According to Anthem, Inc., the data breach extended into multiple brands Anthem, Inc. uses to market its healthcare plans, including, Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross and Blue Shield, Amerigroup, Caremore, and UniCare. Healthlink was also victimized. Anthem says the medical information and financial data was not compromised. Anthem has offered free credit monitoring in the wake of the breach. According to Bloomberg News, China may be responsible for this data breach. Michael Daniel, chief adviser on cybersecurity for President Barack Obama, said he would be changing his own password. About 80 million company records were hacked, stoking fears that the stolen data could be used for identity theft. The compromised information contained names, birthdays, medical IDs, social security numbers, street addresses, e-mail addresses, employment information and income data. In June 2017, Anthem agreed to spend $115M to settle allegations that it failed to adequately protect the data of its clients, the sum was to be spent on two years of services to protect victims from identity theft. In 2019, two Chinese nationals were indicted for the breach.

"Avoidable ER program"

Beginning in 2015, Anthem has been implementing and expanding its "avoidable ER program" which means not reimbursing ER visits when the cause is not covered by the company. A few patients found out that they had been stuck with bills of over $10,000 that Anthem refused to reimburse. According to a 2013 report by the Journal of the American Medical Association, 87 percent of patients initially triaged as non-urgent ended up with a diagnosis that constituted an emergency. Critics derided the scheme, citing that it was unlawful by federal law to cover a person based on diagnosis, not symptoms. It was also considered unsafe, as it pressured patients to diagnose themselves before going to the ER.

Neglecting complaints

In 2017, the California Department of Managed Health Care fined the company $5 million for untimely response to consumer complaints. In 2019, this was settled at $2.8 million.

2019 lawsuit for coercive direct payments

In 2019, Sovereign Health pressed charges against Anthem, alleging that it was using direct payments to compel them to join Anthem's network under unfavorable terms. Sovereign owns facilities that treat people with addiction and mental health problems.

Diagnostics fraud

In March 2020, Anthem was sued by the Department of Justice. The lawsuit alleges that Anthem had submitted inaccurate diagnostics data in order to obtain increased Medicare reimbursements. In October 2022, a judge ordered Anthem to face the lawsuit.

Medicare Advantage star rating

In January 2024, Elevance Health filed a lawsuit with the Department of Health and Human Services (HHS) challenging changes in the Medicare Advantage star rating methodology. Star ratings are tied to key bonus payouts, and due to the new rating system in 2024 ratings have significantly decreased.

Finances

For the fiscal year 2017, Anthem reported earnings of US$3.843 billion, with an annual revenue of US$90.039 billion, an increase of 6.1% over the previous fiscal cycle. Anthem's shares traded at over $183 per share, and its market capitalization was valued at over US$69.1 billion in October 2018.

Recognition

The company was featured on the S&P Dow Jones Sustainability Index from 2018 to 2022, was named by Fortune as one of the 100 Best Companies to Work For, and was included on the Corporate Equality Index's list of Best Places to Work for LGBTQ Equality from 2015 to 2022.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

ELV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$399.76
Market Cap
$88.24B
P/E (TTM)
15.9
EPS (TTM)
$25.21
Revenue (TTM)
$199.12B
Div Yield
1.7%
ROE
13.3%
Debt/Equity
0.7
52W Range
$275 – $436

ELV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $199.12B
10-point trend, +134.6%
2016-12-31 2025-12-31
EPS $25.21
10-point trend, +173.7%
2016-12-31 2025-12-31
Free Cash Flow $3.17B
10-point trend, +21.1%
2016-12-31 2025-12-31
Margins 2.8%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
ELV
Peer Median
P/E (TTM)
5-point trend, -25.2%
15.9
33.8
P/S (TTM)
5-point trend, -51.9%
0.4
0.7
P/B
5-point trend, -43.3%
2.0
3.2
EV / EBITDA
5-point trend, -22.9%
12.7
Price / FCF
5-point trend, +58.3%
27.8

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
ELV
Peer Median
Operating Margin
5-point trend, -33.0%
3.6%
Net Profit Margin
5-point trend, -35.5%
2.8%
0.82%
ROA
5-point trend, -28.4%
4.8%
2.2%
ROE
5-point trend, -21.8%
13.3%
6.2%
ROIC
5-point trend, -17.9%
8.0%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
ELV
Peer Median
Debt / Equity
5-point trend, +14.3%
0.7
99.7
Current Ratio
5-point trend, +4.8%
1.5
1.6
Quick Ratio
5-point trend, +65.3%
0.2

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
ELV
Peer Median
Revenue YoY
5-point trend, +43.6%
12.5%
Revenue CAGR 3Y
5-point trend, +43.6%
8.3%
Revenue CAGR 5Y
5-point trend, +43.6%
10.3%
EPS YoY
5-point trend, +1.0%
-1.8%
Net Income YoY
5-point trend, -8.1%
-5.3%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
ELV
Peer Median
EPS (Diluted)
5-point trend, +1.0%
$25.21

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
ELV
Peer Median
Payout Ratio
5-point trend, +49.3%
27.0%

Dividends Yield, payout ratio, dividend history, 5Y CAGR

Dividend Yield
1.7%
Payout Ratio
27.0%
5Y Div CAGR
Ex-dateAmount
June 10, 2026$1.7200
March 10, 2026$1.7200
Dec. 5, 2025$1.7100
Sept. 10, 2025$1.7100
June 10, 2025$1.7100
March 10, 2025$1.7100
Dec. 5, 2024$1.6300
Sept. 10, 2024$1.6300
June 10, 2024$1.6300
March 7, 2024$1.6300
Dec. 5, 2023$1.4800
Sept. 7, 2023$1.4800
June 8, 2023$1.4800
March 9, 2023$1.4800
Dec. 2, 2022$1.2800
Sept. 8, 2022$1.2800
June 9, 2022$1.2800
March 9, 2022$1.2800
Dec. 2, 2021$1.1300
Sept. 9, 2021$1.1300

ELV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 29 analysts
  • Strong Buy 7 24.1%
  • Buy 12 41.4%
  • Hold 10 34.5%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

21 analysts · 2026-08-20
Median target $457.00 +14.3%
Mean target $449.10 +12.3%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.72%
Period EPS Actual EPS Est Surprise
June 30, 2026 $7.45 $6.27 1.2%
March 31, 2026 $12.58 $10.93 1.6%
Dec. 31, 2025 $3.33 $3.13 0.20%
Sept. 30, 2025 $6.03 $4.98 1.0%
June 30, 2025 $8.84 $9.04 -0.20%
March 31, 2025 $11.97 $11.50 0.47%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ELV $77.37B 13.9 12.5% 2.8% 13.3%
UNH $299.08B 25.0 11.8% 2.7% 12.0%
HUM $50.90B 26.0 10.1% 0.92% 7.0%
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9%
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
ALHC $4.03B 46.1% -0.02% -0.52%
CLOV -5.1 40.3% -4.5% -26.2%
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 13
Annual Income Statement data for ELV
Metric Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +169.5% $199.12B $177.01B $171.34B $156.59B $138.64B $121.87B $104.21B $92.11B $90.04B $84.86B $79.16B $73.87B
Cost of Revenue 9-point trend, +21178000000.00 $21.18B $19.75B $17.29B $13.04B $10.89B $8.95B $1.99B $0 $0 · · ·
SG&A Expense 12-point trend, +78.6% $20.98B $20.02B $20.09B $17.70B $15.92B $17.45B $13.36B $14.02B $12.65B $12.56B $12.53B $11.75B
Operating Income 12-point trend, +62.9% $7.20B $7.86B $8.50B $8.28B $7.56B $6.36B $6.00B $5.43B $4.17B $4.80B $4.75B $4.42B
Interest Expense 10-point trend, +71.5% · · $1.03B $851M $798M $784M $746M $753M $739M $723M $653M $601M
Pretax Income 12-point trend, +53.6% $6.71B $7.90B $7.71B $7.60B $8.00B $6.24B $5.99B $5.07B $3.96B $4.55B $4.63B $4.37B
Income Tax 12-point trend, -42.0% $1.05B $1.93B $1.72B $1.71B $1.85B $1.67B $1.18B $1.32B $121M $2.08B $2.07B $1.81B
Net Income 12-point trend, +120.3% $5.66B $5.98B $5.99B $5.89B $6.16B $4.57B $4.81B $3.75B $3.84B $2.47B $2.56B $2.57B
EPS (Basic) 12-point trend, +171.5% $25.28 $25.81 $25.38 $24.56 $25.26 $18.23 $18.81 $14.53 $14.70 $9.39 $9.73 $9.31
EPS (Diluted) 12-point trend, +180.4% $25.21 $25.68 $25.22 $24.28 $24.95 $17.98 $18.47 $14.19 $14.35 $9.21 $9.38 $8.99
Shares (Basic) 12-point trend, -18.8% 224,000,000 231,700,000 235,900,000 240,000,000 243,800,000 250,800,000 255,500,000 258,100,000 261,500,000 262,900,000 263,000,000 275,900,000
Shares (Diluted) 12-point trend, -21.4% 224,600,000 232,900,000 237,400,000 242,800,000 246,800,000 254,300,000 260,300,000 264,200,000 267,800,000 268,100,000 272,900,000 285,900,000
EBITDA 12-point trend, +97.9% $8.74B $9.26B $10.24B $10.13B $8.79B $7.51B $6.00B $5.43B $4.18B $4.80B $4.75B $4.42B
Balance Sheet 26
Annual Balance Sheet data for ELV
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +341.1% $9.49B $8.29B $6.53B $7.39B $4.88B $5.74B $4.94B $3.93B $3.61B $4.08B $2.11B $2.15B
Other Current Assets 12-point trend, +262.6% $5.34B $4.70B $5.79B $5.28B $4.65B $4.06B $3.02B $2.10B $2.25B $1.78B $1.56B $1.47B
Current Assets 12-point trend, +97.2% $63.00B $58.94B $60.03B $55.62B $51.12B $45.75B $39.03B $34.32B $36.26B $34.31B $30.86B $31.95B
PP&E (Net) 12-point trend, +140.7% $4.68B $4.65B $4.36B $4.32B $3.92B $3.48B $3.13B $2.73B $2.17B $1.98B $2.02B $1.94B
PP&E (Gross) 12-point trend, +132.0% $8.73B $8.33B $7.90B $7.12B $8.26B $7.33B $6.48B $5.55B $4.37B $4.14B $4.06B $3.76B
Accum. Depreciation 12-point trend, +122.8% $4.06B $3.68B $3.54B $2.80B $4.34B $3.84B $3.35B $2.81B $2.20B $2.16B $2.04B $1.82B
Goodwill 12-point trend, +65.9% $28.34B $28.28B $25.32B $24.38B $24.23B $21.69B $20.50B $20.50B $19.23B $17.56B $17.56B $17.08B
Intangibles 12-point trend, +40.7% $11.20B $12.09B $10.27B $10.31B $10.62B $9.40B $8.67B $9.01B $8.37B $7.96B $8.16B $7.96B
Other Non-current Assets 12-point trend, +350.9% $2.31B $2.14B $1.97B $1.69B $1.72B $1.44B $1.35B $758M $565M $468M $485M $512M
Total Assets 12-point trend, +97.0% $121.49B $116.89B $108.93B $102.75B $97.46B $86.61B $77.45B $71.57B $70.54B $65.08B $61.72B $61.68B
Accounts Payable 12-point trend, +100.5% $7.32B $6.93B $6.91B $5.61B $4.97B $5.49B $4.20B $4.96B $5.02B $4.01B $3.32B $3.65B
Short-term Debt 12-point trend, -62.5% $150M $365M $225M $265M $275M $0 $700M $1.15B $1.27B $440M $540M $400M
Current Liabilities 12-point trend, +118.8% $41.03B $40.58B $41.79B $39.70B $34.88B $29.45B $23.53B $21.96B $23.36B $21.29B $19.09B $18.75B
Capital Leases 5-point trend, -38.8% $529M $658M $685M $751M $864M · · · · · · ·
Deferred Tax 12-point trend, -28.4% $2.11B $2.15B $1.97B $2.02B $2.81B $2.02B $2.23B $1.96B $1.73B $2.78B $2.63B $2.95B
Other Non-current Liabilities 12-point trend, +240.4% $3.53B $3.33B $1.74B $1.56B $1.68B $1.81B $1.42B $1.18B $925M $884M $994M $1.04B
Total Liabilities 12-point trend, +107.0% $77.47B $75.46B $69.52B $66.42B $61.29B $53.42B $45.73B $43.03B $44.04B $39.98B $38.67B $37.42B
Long-term Debt 12-point trend, +117.8% $31.90B $30.87B $24.89B $23.85B $22.76B $20.04B $19.39B $18.07B $18.66B $15.29B $15.32B $14.64B
Total Debt 12-point trend, +111.5% $32.05B $31.23B $25.12B $24.11B $23.03B $20.04B $20.09B $19.21B $19.93B $15.73B $15.86B $15.15B
Common Stock 12-point trend, -25.9% $2M $2M $2M $2M $2M $3M $3M $3M $3M $3M $3M $3M
Paid-in Capital 12-point trend, -11.2% $8.94B $8.91B $8.87B $9.08B $9.15B $9.24B $9.45B $9.54B $8.55B $8.81B $8.56B $10.06B
Retained Earnings 12-point trend, +152.5% $35.39B $33.55B $31.75B $29.65B $27.14B $23.80B $22.57B $19.99B $18.05B $16.56B $14.78B $14.01B
AOCI 12-point trend, -362.4% $-451M $-1.15B $-1.31B $-2.49B $-197M $150M $-296M $-986M $-101M $-268M $-293M $172M
Stockholders' Equity 12-point trend, +80.9% $43.88B $41.31B $39.31B $36.24B $36.09B $33.20B $31.73B $28.54B $26.50B $25.10B $23.05B $24.25B
Liabilities + Equity 12-point trend, +97.0% $121.49B $116.89B $108.93B $102.75B $97.46B $86.61B $77.45B $71.57B $70.54B $65.08B $61.72B $61.68B
Shares Outstanding 12-point trend, -17.7% 220,723,898 227,479,695 233,071,088 237,958,067 241,770,746 245,401,430 252,922,161 257,395,577 256,084,913 263,747,395 261,238,188 268,109,932
Cash Flow 18
Annual Cash Flow data for ELV
Metric Trend 202520242023202220212020201920182017201620152014
D&A 8-point trend, +36.6% $1.55B $1.39B $1.75B $1.68B $1.30B $1.15B $1.13B $1.13B · · · ·
Stock-based Comp 12-point trend, +63.4% $276M $191M $289M $264M $255M $283M $294M $226M $170M $165M $148M $169M
Deferred Tax 12-point trend, -1008.8% $-279M $-374M $-602M $-115M $342M $-540M $81M $91M $-1.27B $127M $-66M $31M
Amort. of Intangibles 12-point trend, +184.3% $628M $580M $885M $767M $441M $361M $338M $358M $169M $192M $230M $221M
Other Non-cash 6-point trend, -155.9% $-2.92B $-1.38B $642M $511M $377M $5.22B · · · · · ·
Operating Cash Flow 12-point trend, +27.3% $4.29B $5.81B $8.06B $8.40B $8.36B $10.69B $6.06B $3.83B $4.18B $3.27B $4.21B $3.37B
CapEx 12-point trend, +56.2% $1.12B $1.26B $1.30B $1.15B $1.09B $1.02B $1.08B $1.21B $791M $584M $638M $715M
Investing Cash Flow 12-point trend, -37.9% $-1.34B $-5.17B $-5.57B $-4.56B $-9.64B $-7.32B $-2.79B $-1.26B $-5.08B $-514M $-1.15B $-975M
Debt Issued 12-point trend, +10.8% $2.99B $7.71B $2.57B $3.07B $3.46B $2.48B $2.47B $835M $5.46B $0 $1.23B $2.70B
Net Debt Issued 12-point trend, -13.0% $844M $6.06B $665M $1.17B $2.39B $552M $1.35B $-849M $2.64B $0 $-1.47B $970M
Stock Issued 5-point trend, +0.00 · · · · · $0 $0 $1.25B $0 $0 · ·
Stock Repurchased 12-point trend, -13.1% $2.60B $2.90B $2.68B $2.32B $1.90B $2.70B $1.70B $1.69B $2.00B $0 $1.52B $3.00B
Net Stock Activity 12-point trend, +13.1% $-2.60B $-2.90B $-2.68B $-2.32B $-1.90B $-2.70B $-1.70B $-435M $-2.00B $0 $-1.52B $-3.00B
Dividends Paid 12-point trend, +218.1% $1.53B $1.51B $1.40B $1.23B $1.10B $954M $818M $776M $705M $684M $657M $481M
Financing Cash Flow 12-point trend, +4.6% $-1.74B $1.19B $-3.35B $-1.32B $423M $-2.57B $-2.27B $-2.24B $427M $-799M $-3.09B $-1.82B
Net Change in Cash 12-point trend, +113.0% $1.20B $1.83B $-861M $2.51B $-861M $804M $1.00B $325M $-466M $1.96B $-38M $565M
Free Cash Flow 12-point trend, +19.6% $3.17B $4.55B $6.76B $7.25B $7.28B $9.67B $4.98B $2.62B $3.39B $2.62B $3.48B $2.65B
Levered FCF 10-point trend, +159.1% · · $5.97B $6.59B $6.66B $9.09B $4.38B $2.06B $2.67B $2.23B $3.12B $2.30B
Profitability 7
Annual Profitability data for ELV
Metric Trend 202520242023202220212020201920182017201620152014
Operating Margin 12-point trend, -39.5% 3.6% 4.4% 5.0% 5.4% 5.4% 5.2% 5.8% 5.9% 4.6% 5.7% 6.0% 6.0%
Net Margin 12-point trend, -18.4% 2.8% 3.4% 3.5% 3.9% 4.4% 3.8% 4.6% 4.1% 4.3% 2.9% 3.2% 3.5%
Pretax Margin 12-point trend, -43.0% 3.4% 4.5% 4.5% 5.0% 5.7% 5.1% 5.7% 5.5% 4.4% 5.4% 5.9% 5.9%
EBITDA Margin 12-point trend, -26.6% 4.4% 5.2% 6.0% 6.5% 6.3% 6.2% 5.8% 5.9% 4.6% 5.7% 6.0% 6.0%
ROA 12-point trend, +12.3% 4.8% 5.3% 5.7% 6.0% 6.6% 5.6% 6.5% 5.3% 5.7% 3.9% 4.2% 4.2%
ROE 12-point trend, +25.5% 13.3% 14.8% 15.8% 16.7% 17.0% 13.6% 15.2% 13.0% 14.6% 9.9% 11.1% 10.6%
ROIC 12-point trend, +21.8% 8.0% 8.2% 10.2% 10.8% 9.8% 8.8% 9.3% 8.4% 8.7% 6.4% 6.8% 6.6%
Liquidity & Solvency 5
Annual Liquidity & Solvency data for ELV
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, -10.7% 1.5 1.5 1.4 1.4 1.5 1.6 1.7 1.6 1.6 1.6 1.6 1.7
Quick Ratio 12-point trend, +101.7% 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.1
Debt / Equity 12-point trend, +16.9% 0.7 0.8 0.6 0.7 0.6 0.6 0.6 0.7 0.8 0.6 0.7 0.6
LT Debt / Equity 12-point trend, +20.5% 0.7 0.7 0.6 0.6 0.6 0.6 0.6 0.6 0.7 0.6 0.7 0.6
Interest Coverage 10-point trend, +12.2% · · 8.3 9.9 9.4 8.1 8.0 7.2 5.7 6.6 7.3 7.4
Efficiency 1
Annual Efficiency data for ELV
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, +37.5% 1.7 1.6 1.6 1.6 1.5 1.5 1.4 1.3 1.3 1.3 1.3 1.2
Per Share 6
Annual Per Share data for ELV
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +119.8% $198.81 $181.62 $168.64 $152.58 $149.15 $135.28 $125.45 $110.88 $103.49 $95.17 $88.21 $90.45
Revenue / Share 12-point trend, +243.1% $886.58 $760.03 $721.74 $644.95 $561.75 $479.23 $400.36 $348.62 $336.22 $316.53 $290.06 $258.39
Cash Flow / Share 12-point trend, +62.1% $19.10 $24.94 $33.96 $34.59 $33.89 $42.03 $23.28 $14.49 $15.63 $11.95 $15.08 $11.78
Cash / Share 12-point trend, +435.8% $43.00 $36.43 $28.00 $31.04 $20.18 $23.39 $19.52 $15.28 $14.09 $15.45 $8.09 $8.03
Dividend / Share 10-point trend, +238.3% · · $6 $5 $5 $4 $3 $3 $3 $3 $2 $2
EPS (TTM) 12-point trend, +180.4% $25.21 $25.68 $25.22 $24.28 $24.95 $17.98 $18.47 $14.19 $14.35 $9.21 $9.38 $8.99
Growth Rates 10
Annual Growth Rates data for ELV
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -9.2% 12.5% 3.3% 9.4% 13.0% 13.8% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -30.7% 8.3% 8.5% 12.0% · · · · · · · · ·
Revenue CAGR 5Y 10.3% · · · · · · · · · · ·
EPS YoY 5-point trend, -104.7% -1.8% 1.8% 3.9% -2.7% 38.8% · · · · · · ·
EPS CAGR 3Y 3-point trend, -89.4% 1.3% 0.97% 11.9% · · · · · · · · ·
EPS CAGR 5Y 7.0% · · · · · · · · · · ·
Net Income YoY 5-point trend, -115.3% -5.3% -0.12% 1.6% -4.3% 34.7% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -114.1% -1.3% -0.97% 9.4% · · · · · · · · ·
Net Income CAGR 5Y 4.4% · · · · · · · · · · ·
Dividend CAGR 5Y 9.9% · · · · · · · · · · ·
Valuation (TTM) 17
Annual Valuation (TTM) data for ELV
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +169.5% $199.12B $177.01B $171.34B $156.59B $138.64B $121.87B $104.21B $92.11B $90.04B $84.86B $79.16B $73.87B
Net Income TTM 12-point trend, +120.3% $5.66B $5.98B $5.99B $5.89B $6.16B $4.57B $4.81B $3.75B $3.84B $2.47B $2.56B $2.57B
Market Cap 12-point trend, +129.6% $77.37B $83.92B $109.91B $122.07B $112.07B $78.80B $76.39B $67.60B $57.62B $37.92B $36.43B $33.69B
Enterprise Value 12-point trend, +114.0% $99.93B $106.86B $128.50B $138.79B $130.22B $93.09B $91.54B $82.88B $73.94B $49.57B $50.18B $46.69B
P/E 12-point trend, -0.5% 13.9 14.4 18.7 21.1 18.6 17.9 16.4 18.5 15.7 15.6 14.9 14.0
P/S 12-point trend, -14.8% 0.4 0.5 0.6 0.8 0.8 0.6 0.7 0.7 0.6 0.4 0.5 0.5
P/B 12-point trend, +26.9% 1.8 2.0 2.8 3.4 3.1 2.4 2.4 2.4 2.2 1.5 1.6 1.4
P / Tangible Book 6-point trend, -52.4% 17.8 88.9 29.6 79.0 89.5 37.5 · · · · · ·
P / Cash Flow 12-point trend, +80.4% 18.0 14.4 13.6 14.5 13.4 7.4 12.6 17.7 13.8 11.8 8.9 10.0
P / FCF 12-point trend, +92.1% 24.4 18.4 16.2 16.8 15.4 8.2 15.3 25.8 17.0 14.5 10.5 12.7
EV / EBITDA 12-point trend, +8.1% 11.4 11.5 12.5 13.7 14.8 12.4 15.3 15.3 17.7 10.3 10.6 10.6
EV / FCF 12-point trend, +79.0% 31.5 23.5 19.0 19.2 17.9 9.6 18.4 31.6 21.8 18.9 14.4 17.6
EV / Revenue 12-point trend, -20.6% 0.5 0.6 0.8 0.9 0.9 0.8 0.9 0.9 0.8 0.6 0.6 0.6
Dividend Yield 12-point trend, +38.5% 2.0% 1.8% 1.3% 1.0% 0.99% 1.2% 1.1% 1.1% 1.2% 1.8% 1.8% 1.4%
Earnings Yield 12-point trend, +0.6% 7.2% 7.0% 5.3% 4.7% 5.4% 5.6% 6.1% 5.4% 6.4% 6.4% 6.7% 7.1%
Payout Ratio 12-point trend, +44.3% 27.0% 25.2% 23.3% 20.4% 18.1% 20.9% 17.0% 20.7% 18.3% 27.7% 25.7% 18.7%
Annual Payout 12-point trend, +218.1% $1.53B $1.51B $1.40B $1.23B $1.10B $954M $818M $776M $705M $684M $657M $481M

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $199.12B$177.01B$171.34B$156.59B$138.64B
Operating Margin % 3.6%4.4%5.0%5.4%5.4%
Net Income $5.66B$5.98B$5.99B$5.89B$6.16B
Diluted EPS $25.21$25.68$25.22$24.28$24.95
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity 0.70.80.60.70.6
Current Ratio 1.51.51.41.41.5
Quick Ratio 0.20.20.20.20.1
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $3.17B$4.55B$6.76B$7.25B$7.28B

Latest News Recent headlines mentioning this company

Trading Signals Recent buy/sell signals with entry price and risk/reward ratio

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 1,772 filers · $54.8B total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
264 (+95 vs prior Q) 94 (-108 vs prior Q) 589 (+108 vs prior Q) 541 (-102 vs prior Q) +7.9M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $7,274,315,633 20,751,150 13.26% Shares
VANGUARD CAPITAL MANAGEMENT LLC $5,436,729,233 14,058,204 9.91% Shares
STATE STREET CORP $4,032,282,885 10,426,610 7.35% Shares
WELLINGTON MANAGEMENT GROUP LLP $3,179,014,962 8,220,244 5.80% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $2,403,277,896 6,214,356 4.38% Shares
Sanders Capital, LLC $2,252,711,532 5,825,024 4.11% Shares
Artisan Partners Limited Partnership $1,771,695,984 4,581,222 3.23% Shares
GEODE CAPITAL MANAGEMENT, LLC $1,712,764,692 4,448,634 3.12% Shares
NORGES BANK $1,531,008,381 3,958,856 2.79% Shares
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $779,725,026 2,016,200 1.42% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $697,513,963 1,803,620 1.27% Shares
Grantham, Mayo, Van Otterloo & Co. LLC $654,221,093 1,691,671 1.19% Shares
FMR LLC $633,317,160 1,637,621 1.15% Shares
MANUFACTURERS LIFE INSURANCE COMPANY, THE $591,084,393 1,528,416 1.08% Shares
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $588,871,451 1,522,694 1.07% Shares
EAGLE CAPITAL MANAGEMENT LLC $576,772,638 1,491,409 1.05% Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $511,706,827 1,323,163 0.93% Shares
DIMENSIONAL FUND ADVISORS LP $511,575,693 1,322,824 0.93% Shares
VANGUARD FIDUCIARY TRUST CO $461,498,831 1,193,336 0.84% Shares
Ruane, Cunniff & Goldfarb L.P. $378,839,935 979,598 0.69% Shares
Brave Warrior Advisors, LLC $377,790,736 976,885 0.69% Shares
Newport Trust Company, LLC $369,294,278 954,915 0.67% Shares
1832 Asset Management L.P. $355,109,795 918,237 0.65% Shares
CITADEL ADVISORS LLC $293,751,600 759,578 0.54% Shares
Capital International Investors $290,732,899 751,772 0.53% Shares
MILLENNIUM MANAGEMENT LLC $281,369,666 727,561 0.51% Shares
BlackRock, Inc. $268,353,881 693,905 0.49% Shares
High Ground Investment Management LLP $262,939,273 679,904 0.48% Shares
CANADA PENSION PLAN INVESTMENT BOARD $261,530,030 676,260 0.48% Shares
Legal & General Group Plc $259,012,033 669,749 0.47% Shares
ACR Alpine Capital Research, LLC $254,804,222 658,869 0.46% Shares
Qube Research & Technologies Ltd $247,577,198 640,181 0.45% Shares
VICTORY CAPITAL MANAGEMENT INC $240,259,106 621,258 0.44% Shares
Swiss National Bank $239,610,173 619,580 0.44% Shares
CAPITOLIS LIQUID GLOBAL MARKETS LLC $237,525,699 614,190 0.43% Shares
National Pension Service $228,059,708 589,713 0.42% Shares
GOLDMAN SACHS GROUP INC $222,913,559 576,406 0.41% Shares
Sumitomo Mitsui Trust Group, Inc. $220,953,931 571,339 0.40% Shares
Mitsubishi UFJ Asset Management Co., Ltd. $205,911,600 532,437 0.38% Shares
Ninety One UK Ltd $196,567,097 508,280 0.36% Shares
ALLIANCEBERNSTEIN L.P. $191,531,395 654,249 0.35% Shares
FIRST TRUST ADVISORS LP $189,503,803 490,016 0.35% Shares
Vanguard Global Advisers, LLC $183,654,210 474,890 0.33% Shares
ENVESTNET ASSET MANAGEMENT INC $181,045,755 468,145 0.33% Shares
8 KNOTS MANAGEMENT, LLC $179,336,122 511,585 0.33% Shares
Focused Investors LLC $178,514,568 461,600 0.33% Shares
Nuveen Asset Management, LLC $171,198,670 464,079 0.31% Shares
DAVENPORT & Co LLC $171,104,235 441,940 0.31% Shares
VANGUARD ASSET MANAGEMENT, Ltd $167,143,159 432,196 0.30% Shares
Veritas Asset Management LLP $165,780,323 428,672 0.30% Shares
RHUMBLINE ADVISERS $161,791,876 418,359 0.29% Shares
California Public Employees Retirement System $157,606,784 407,537 0.29% Shares
FIL Ltd $157,293,146 406,726 0.29% Shares
MANNING & NAPIER ADVISORS LLC $142,522,435 367,297 0.26% Shares
Canoe Financial LP $140,577,902 363,504 0.26% Shares
YACKTMAN ASSET MANAGEMENT LP $131,482,399 339,985 0.24% Shares
BANK OF AMERICA CORP /DE/ $121,697,356 314,683 0.22% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $121,433,220 314,000 0.22% Put option
AMERIPRISE FINANCIAL INC $119,565,700 309,171 0.22% Shares
Swedbank AB $116,986,211 302,501 0.21% Shares
Assenagon Asset Management S.A. $115,776,907 299,374 0.21% Shares
M&G PLC $114,210,666 295,118 0.21% Shares
Quantinno Capital Management LP $112,935,724 292,027 0.21% Shares
Universal- Beteiligungs- und Servicegesellschaft mbH $112,933,654 282,040 0.21% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $107,897,670 279,000 0.20% Call option
BANK OF NOVA SCOTIA $101,450,881 262,330 0.18% Shares
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $96,843,749 330,807 0.18% Shares
Diamond Hill Capital Management, LLC (Investment Advisor) $96,574,989 249,722 0.18% Shares
Caisse de depot et placement du Quebec $94,418,969 244,147 0.17% Shares
Sound Shore Management Inc /CT/ $94,150,192 243,452 0.17% Shares
NEW YORK STATE COMMON RETIREMENT FUND $93,705,452 242,302 0.17% Shares
AMF Tjanstepension AB $92,093,175 238,133 0.17% Shares
BNP PARIBAS FINANCIAL MARKETS $91,136,405 235,659 0.17% Shares
MACKENZIE FINANCIAL CORP $90,587,635 234,240 0.17% Shares
ROYAL LONDON ASSET MANAGEMENT LTD $89,603,021 231,694 0.16% Shares
JANE STREET GROUP, LLC $87,130,269 225,300 0.16% Call option
PZENA INVESTMENT MANAGEMENT LLC $86,849,890 224,575 0.16% Shares
Marathon Asset Management Ltd $84,882,114 219,490 0.15% Shares
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $84,674,534 218,950 0.15% Shares
BARCLAYS PLC $79,161,697 204,695 0.14% Shares
RENAISSANCE TECHNOLOGIES LLC $77,876,980 201,373 0.14% Shares
CITADEL ADVISORS LLC $77,152,635 199,500 0.14% Put option
AVIVA PLC $77,089,211 199,336 0.14% Shares
TD Asset Management Inc $75,328,430 194,783 0.14% Shares
Maple Rock Capital Partners Inc. $74,058,795 191,500 0.14% Shares
Mawer Investment Management Ltd. $72,431,822 187,293 0.13% Shares
Freestone Grove Partners LP $72,096,914 186,427 0.13% Shares
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $71,577,149 185,083 0.13% Shares
Zurcher Kantonalbank (Zurich Cantonalbank) $71,371,408 184,551 0.13% Shares
Orbis Allan Gray Ltd $70,845,455 183,191 0.13% Shares
Jefferies Financial Group Inc. $69,850,785 180,619 0.13% Shares
CITADEL ADVISORS LLC $69,069,978 178,600 0.13% Call option
Korea Investment CORP $68,952,025 178,295 0.13% Shares
Harvest Portfolios Group Inc. $68,795,400 177,890 0.13% Shares
RAYMOND JAMES FINANCIAL INC $68,556,341 177,272 0.12% Shares
LPL Financial LLC $67,831,262 175,397 0.12% Shares
Alyeska Investment Group, L.P. $67,228,756 173,839 0.12% Shares
Robeco Institutional Asset Management B.V. $66,324,193 171,500 0.12% Shares
APG Asset Management N.V. $66,031,619 195,211 0.12% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $66,009,784 170,687 0.12% Shares

Company insiders 92 insiders · 55 officers · 36 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Gail Boudreaux President and CEO July 17, 2026 P 171,976 2 0 $1,002,230
Brian T Griffin EVP & CEO, IngenioRx May 3, 2018 M 15,863 0 0 $0
Angela F Braly Chair, President & CEO March 1, 2012 A 476,503 0 0 $0
Brian A Sassi President & CEO Cons, EVP June 7, 2011 S 60,825 0 0 $0
Dijuana K Lewis Pres & CEO CHS and EVP May 20, 2010 M 44,107 0 0 $0
Mark L Boxer Pres & CEO of OT&GS and EVP April 4, 2008 F 42,143 0 0 $0
Joan E Herman President & CEO Cons and EVP Dec. 7, 2007 S 30,369 0 0 $0
Mark Kaye EVP & CFO April 24, 2025 S 18,977 0 0 $0
John E Gallina EVP & Chief Financial Officer March 1, 2023 A 63,725 0 0 $0
Wayne S Deveydt EVP & Chief Financial Officer March 3, 2016 F 57,957 0 0 $0
David C Colby Vice Chairman, CFO & EVP April 4, 2007 F 343,071 0 0 $0
Thomas R Byrd President, Anthem Specialty Nov. 26, 2004 A 26,580 0 0 $0
Michael D Houk President, National Accounts Nov. 4, 2004 M 18,843 0 0 $0
John M Murphy President, Specialty Business May 17, 2004 A 20,806 0 0 $0
Caroline S Matthews Chief Operating Officer Dec. 1, 2004 A 40,471 0 0 $0
Ronald W Penczek CAO & Controller June 12, 2026 S 3,740 0 1 $-148,766
Charles Morgan Kendrick JR EVP & President, Commercial March 3, 2025 A 10,116 0 0 $0
Felicia F Norwood EVP & President,Gov Health Ben March 3, 2025 A 31,939 0 0 $0
Ratnakar Lavu EVP, Chief Digital & Info Off March 3, 2025 A 4,783 0 0 $0
Peter D Haytaian EVP & Pres Carelon & CarelonRx March 3, 2025 A 26,004 0 0 $0
Blair Williams Todt EVP, CLO & CAO Jan. 3, 2025 F 15,631 0 0 $0
Gloria M Mccarthy EVP & Chief Administrative Off March 24, 2023 S 51,435 0 0 $0
Leah Stark EVP & CHRO Dec. 30, 2021 F 12,403 0 0 $0
Jeffrey D. Alter EVP, IngenioRx & Anthem Health Oct. 1, 2021 F 5,107 0 0 $0
Patel Prakash R EVP & President, DBG Sept. 4, 2021 F 17,230 0 0 $0
Thomas C Zielinski EVP & General Counsel Nov. 3, 2020 M 17,910 0 0 $0
Craig E Samitt EVP & President, DBG July 26, 2018 M 17,274 0 0 $0
Joseph Swedish Executive Chairman March 5, 2018 S 61,419 0 0 $0
Jacquelyn H Wolf EVP & Chief HR Officer March 1, 2018 A 3,105 0 0 $0
Jose D. Tomas EVP & Chief HR Officer March 3, 2017 F 23,927 0 0 $0
Samuel R Nussbaum MD EVP & Chief Medical Officer May 19, 2015 M 110,973 0 0 $0
Martin B Silverstein EVP & Chief Strategy Officer May 1, 2015 F 23,249 0 0 $0
Kenneth R Goulet EVP, Commercial & Specialty March 2, 2015 A 84,281 0 0 $0
Richard C Zoretic EVP, Gov Business Division March 3, 2014 A 53,572 0 0 $0
John Cannon EVP, GC & Chief PAO Dec. 13, 2013 S 99,331 0 0 $0
Randal L Brown EVP & Chief HR Officer Sept. 4, 2013 M 30,332 0 0 $0
Lori A Beer EVP, Specialty Businesses & IT May 30, 2013 M 113,955 0 0 $0
Harlan A Levine EVP, CHS Aug. 31, 2012 S 25,244 0 0 $0
Venkata R Madabhushi EVP Sr Bus & Chf Transfrmn Off April 2, 2012 A 45,237 0 0 $0
Miller Martin SVP & Chief Accounting Officer March 1, 2011 A 29,329 0 0 $0
Fluegel M Bradley EVP, Chief Strategy Officer Nov. 5, 2010 M 52,634 0 0 $0
Cynthia S Miller EVP & Chief Actuary March 1, 2010 A 60,757 0 0 $0
Randall J Lewis EVP & Chief Compliance Officer Aug. 7, 2009 M 13,658 0 0 $0
Jamie S Miller SVP & Chief Accounting Officer March 3, 2008 A 25,710 0 0 $0
Alice F Rosenblatt EVP and Chief Actuary Jan. 22, 2008 S 39,265 0 0 $0
John S Watts JR EVP Dec. 7, 2007 S 108,311 0 0 $0
Marjorie W Dorr EVP May 22, 2007 M 38,951 0 0 $0
Michael A Stocker EVP Oct. 23, 2006 M 42,186 0 0 $0
Keith R Faller EVP Sept. 12, 2006 M 83,290 0 0 $0
David S Helwig EVP Aug. 18, 2006 M 55,055 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 218 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IHF · iShares Trust 7.20% 221,824 SH Aug. 21, 2026 Daily
GFGF · EA Series Trust 3.75% 3,541 NS May 29, 2026 N-PORT
MDPL · Northern Lights Fund Trust IV 3.24% 5,013 NS May 31, 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 2.78% 64,637 NS April 30, 2026 N-PORT
ABCS · EA Series Trust 2.29% 661 NS May 29, 2026 N-PORT
FEGE · RBB Fund Trust 1.92% 94,302 NS May 31, 2026 N-PORT
QLTY · GMO ETF Trust 1.75% 200,065 NS May 31, 2026 N-PORT
TOLL · Tema ETF Trust 1.71% 2,139 NS May 31, 2026 N-PORT
SRHQ · Elevation Series Trust 1.54% 7,891 NS April 30, 2026 N-PORT
BKDV · BNY Mellon ETF Trust II 1.52% 55,921 NS April 30, 2026 N-PORT
RPV · Invesco Exchange-Traded Fund Trust 1.51% 66,138 SH Aug. 21, 2026 Daily
RSPH · Invesco Exchange-Traded Fund Trust 1.41% 29,279 SH Aug. 21, 2026 Daily
FHLC · FIDELITY COVINGTON TRUST 1.35% 102,444 NS April 30, 2026 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 1.33% 62,208 SH Aug. 21, 2026 Daily
IYH · iShares Trust 1.33% 129,500 SH Aug. 21, 2026 Daily
RXL · ProShares Trust 1.26% 2,301 NS May 31, 2026 N-PORT
VMAX · Lattice Strategies Trust 1.25% 1,543 NS April 30, 2026 N-PORT
VHT · VANGUARD WORLD FUND 1.22% 645,908 SH Aug. 19, 2026 Daily
CURE · Direxion Shares ETF Trust 1.20% 4,402 NS April 30, 2026 N-PORT
IMCV · iShares Trust 1.14% 34,017 SH Aug. 21, 2026 Daily
FTA · First Trust Exchange-Traded AlphaDE… 1.12% 38,663 NS April 30, 2026 N-PORT
SURE · AdvisorShares Trust 1.09% 1,600 NS June 30, 2026 N-PORT
NUDV · Nushares ETF Trust 1.09% 1,312 NS April 30, 2026 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 1.06% 278 NS May 31, 2026 N-PORT
IXJ · iShares Trust 1.04% 114,143 SH Aug. 21, 2026 Daily
MFSV · MFS Active Exchange Traded Funds Tr… 1.04% 12,508 NS May 31, 2026 N-PORT
PY · Principal Exchange-Traded Funds 1.04% 5,907 NS June 30, 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 0.97% 241,912 SH Aug. 21, 2026 Daily
RDVI · First Trust Exchange-Traded Fund IV 0.96% 78,591 NS April 30, 2026 N-PORT
PALC · Pacer Funds Trust 0.96% 5,883 NS April 30, 2026 N-PORT
ESMV · iShares Trust 0.95% 190 SH Aug. 21, 2026 Daily
GMOV · GMO ETF Trust 0.93% 2,152 NS May 31, 2026 N-PORT
EQIN · Columbia ETF Trust I 0.90% 6,636 NS April 30, 2026 N-PORT
ROUS · Lattice Strategies Trust 0.77% 12,014 NS April 30, 2026 N-PORT
NULC · Nushares ETF Trust 0.73% 1,105 NS April 30, 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0.73% 15,896 SH Aug. 19, 2026 Daily
FCTR · First Trust Exchange-Traded Fund 0.67% 991 NS June 30, 2026 N-PORT
VLUE · iShares Trust 0.67% 164,189 SH Aug. 21, 2026 Daily
CVY · Invesco Exchange-Traded Fund Trust 0.65% 2,045 SH Aug. 21, 2026 Daily
FEUS · FlexShares Trust 0.64% 1,881 NS April 30, 2026 N-PORT
FDLO · FIDELITY COVINGTON TRUST 0.62% 23,028 NS April 30, 2026 N-PORT
COPY · RBB Fund Trust 0.60% 5,260 NS May 31, 2026 N-PORT
FBCV · FIDELITY COVINGTON TRUST 0.60% 2,551 NS April 30, 2026 N-PORT
IDRV · iShares Trust 0.58% 129,150 SH Aug. 21, 2026 Daily
IMCB · iShares Trust 0.56% 24,206 SH Aug. 21, 2026 Daily
FAB · First Trust Exchange-Traded AlphaDE… 0.55% 2,039 NS April 30, 2026 N-PORT
RDVY · First Trust Exchange-Traded Fund VI 0.54% 340,757 NS June 30, 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0.53% 20,983 NS April 30, 2026 N-PORT
IUS · Invesco Exchange-Traded Self-Indexe… 0.51% 12,437 SH Aug. 21, 2026 Daily
FNDX · SCHWAB STRATEGIC TRUST 0.51% 327,388 NS May 31, 2026 N-PORT